Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides

Committee’s Recommendation on BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax Marks a Major Step Toward Closing the Gray Market Enhanced Positioned to Benefit as the Regulatory Pathway Advances Enhanced Group Inc.